Anti-malarials exert a protective effect while Mestizo patients are at increased risk of developing SLE renal disease: data from a Latin-American cohort.
about
Mestizos with systemic lupus erythematosus develop renal disease early while antimalarials retard its appearance: data from a Latin American cohort.Primary cardiac disease in systemic lupus erythematosus patients: protective and risk factors--data from a multi-ethnic Latin American cohort.Early discoid lupus erythematosus protects against renal disease in patients with systemic lupus erythematosus: longitudinal data from a large Latin American cohort.Cardiovascular involvement in autoimmune diseases.Incidence and prevalence of lupus in Buenos Aires, Argentina: a 11-year health management organisation-based studyCharacterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER).Prevalence of musculoskeletal disorders and rheumatic diseases in the indigenous Qom population of Rosario, Argentina.Lupus in Latin-American patients: lessons from the GLADEL cohort.Disease characterization of systemic lupus erythematosus (SLE) patients in Quebec.Long-term Outcome of Lupus Nephritis Class II in Argentine Patients: An Open Retrospective Analysis.Cumulative dose of hydroxychloroquine is associated with a decrease of resting heart rate in patients with systemic lupus erythematosus: a pilot study.Ethnicity in systemic lupus erythematosus (SLE): its influence on susceptibility and outcomes.Predictors of incident proteinuria among patients with SLE.
P2860
Q30655475-DD4D53F2-BC65-45B4-858B-00B687330C16Q30778909-D69BCD84-242E-42A9-BD23-82630CE140D4Q31102783-E2ACCA9F-806B-4396-90D2-0DB0F8D16DE4Q34081242-37939389-6AC5-4FCC-BC67-695B2BDCF1C7Q34424638-3FFF9BFD-B0D9-4C28-AB57-4A8CC18715B7Q36663933-2ADFC5C9-80AC-402B-95D8-CA104D7FAF3BQ37112434-1603F776-67F2-4768-AF8D-0AE85F231F31Q38362113-4AE97FB0-83DF-4667-947E-473FFCF7726FQ38971528-EE7DBEE1-E8AE-4345-BD95-9FC6FDAE5B78Q39789199-1F6674DC-B160-47DE-95D9-27D53BFA8B24Q40161775-E484E84E-0852-461F-A877-1BDAEAE02B00Q46496211-68366557-29BD-4A01-8199-915F2FC21458Q47100353-E6EE2876-0789-47A9-9327-2C245DCCB5FB
P2860
Anti-malarials exert a protective effect while Mestizo patients are at increased risk of developing SLE renal disease: data from a Latin-American cohort.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Anti-malarials exert a protect ...... from a Latin-American cohort.
@ast
Anti-malarials exert a protect ...... from a Latin-American cohort.
@en
Anti-malarials exert a protect ...... from a Latin-American cohort.
@nl
type
label
Anti-malarials exert a protect ...... from a Latin-American cohort.
@ast
Anti-malarials exert a protect ...... from a Latin-American cohort.
@en
Anti-malarials exert a protect ...... from a Latin-American cohort.
@nl
prefLabel
Anti-malarials exert a protect ...... from a Latin-American cohort.
@ast
Anti-malarials exert a protect ...... from a Latin-American cohort.
@en
Anti-malarials exert a protect ...... from a Latin-American cohort.
@nl
P2093
P2860
P356
P1433
P1476
Anti-malarials exert a protect ...... from a Latin-American cohort.
@en
P2093
Bernardo A Pons-Estel
Daniel Wojdyla
Fernando S Cavalcanti
Gabriela Boggio
Graciela S Alarcón
Leticia Hachuel
Magaly Alva
Maria H Esteva-Spinetti
Maria J Sauza Del Pozo
P2860
P304
P356
10.1093/RHEUMATOLOGY/KER514
P577
2012-03-02T00:00:00Z